Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome vs bupivacaine for postoperative pain after total hip replacement
ChiCTR2400087828Phase 4Recruiting
- Sponsor
- Nanjing Medical University Affiliated Nanjing Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Nanjing Medical University Affiliated Nanjing Hospital. Primary endpoints: Rest visual analogue scale (RvAS), Passive visual analogue scale (PVAS) and 1 more. Started Aug 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400087828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087828.